enVVeno Medical (NASDAQ:NVNO) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

enVVeno Medical (NASDAQ:NVNO) released its quarterly earnings data on Thursday. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Stock Performance

Shares of enVVeno Medical stock traded down $0.35 on Friday, hitting $3.18. 239,342 shares of the company traded hands, compared to its average volume of 111,170. The business has a 50-day simple moving average of $3.27 and a 200 day simple moving average of $3.70. enVVeno Medical has a 52 week low of $2.45 and a 52 week high of $6.97. The stock has a market capitalization of $55.76 million, a P/E ratio of -2.47 and a beta of 1.22.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).